02 - Research Motivations - Interview with Dr. Jean-Pierre Issa - YouTube
First clinical results of a randomized phase 2 study of SGI-110, a novel subcutaneous (SQ) hypomethylating agent (HMA), in adult
Hussein A. Abbas | MD Anderson Cancer Center
Interview with Dr. Jean-Pierre Issa | CancerQuest
Jean-Pierre Issa, MD, Coriell Institute for Medical Research, presents "Epigenetics in aging, cancer and cancer therapy"
DNA methylation changes in aging cells and tissues | HSTalks
.jpg?mw=240 "The Team")
The Team
Dr. Jean-Pierre Issa, MD | Philadelphia, PA | Internal Medicine | Vitals
Prof. Jean-Pierre Issa | HSTalks
Jean-Pierre J. Issa's research works | Coriell Institute for Medical Research, Camden and other places
Spotlight On: Jean-Pierre Issa, President and CEO, Coriell Institute for Medical Research - Capital Analytics
PRWeek Pride in PR: Karine Jean-Pierre | PR Week
Jean-Pierre Issa, MD, Philadelphia, PA | Oncologist
TAT 2011 presentation: Discovery and development of next generation epigenetic DNMT inhibitors: Development of SGI-110, a novel
Leadership - Epigen Oncology
Jean-Pierre Issa - President and CEO - Coriell Institute for Medical Research | LinkedIn
Pulling Back the Curtain: Allen Yang, MD, PhD
Press Releases
NOVA | Ghost in Your Genes | Epigenetic Therapy | PBS
Dr. Jean-Pierre Issa Details the Positive Impacts of Reducing Caloric Intake | Temple Health
Our Faculty | Jean-Pierre Issa | Coriell Institute
